4D Molecular Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
4D Molecular Therapeutics, Inc. (FDMT) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.15 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-15.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-15
- 4D Molecular Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-06-30 was $1.15M.
- 4D Molecular Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $1.15M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 1 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2021-12-31 | $1.15M 10-K · filed 2023-03-15 | ||
| 2021-06-30 | $1.15M 10-Q · filed 2022-11-08 | ||
| 2018-05-31 | $100.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Entera Bio Ltd. (ENTX) | $0.485B |